News | September 13, 2013

New technology enables real-time X-ray monitoring of internal motion during radiotherapy delivery

tumor localization systems, tumor localization, elekta, radiation therapy

Elekta X-ray Volume Imaging (XVI)

September 13, 2013 – Integrated with Versa HD linear accelerator, Elekta has introduced new intra-fraction imaging capabilities within its X-ray Volume Imaging (XVI) system. During treatment, XVI now provides the tools to monitor and manage internal motion, supporting the clinician's efforts to increase therapeutic doses delivered to the tumor while reducing healthy tissue exposure.

"Regardless of patient immobilization, both the tumor and adjacent critical structures may move during treatment delivery. Historically, this has presented a significant challenge in delivering highly targeted treatments," says Dee Mathieson, Senior Vice President, Oncology Business Line Management.

"On a second by second basis, the precise location of the tumor and sensitive healthy structures can now be visualized, helping clinicians accurately deliver dose to the tumor while minimizing normal tissue exposure,” she adds

Elekta's XVI, which is also available on other Elekta radiotherapy delivery systems, includes 2-D, 3-D and 4-D intra-fraction imaging to support live imaging during sophisticated delivery techniques, such as Volumetric Modulated Arc Therapy (VMAT).

The new capabilities within XVI include seamless integration with Elekta's Mosaiq image-enabled oncology information system. XVI and Mosaiq work in harmony to deliver highly automated imaging workflow for improved control, efficiency, and performance. With image data available within the Oncology Information System, patient images, as well as setup and correction data, can be accessed as an integral part of the patient's electronic medical record.

The XVI 5.0 is pending FDA 510(k) clearance and not yet available for sale in the United States.

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation